Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Pediatric Oncology
What is the optimal salvage therapy for a patient with a relapsed primary mediastinal yolk sac tumor with brain metastases?
Optimal salvage chemotherapy?
Role/type of transplant?
Role for RT?
Role for surgery/neurosurgery?
Related Questions
In which settings would you use external beam radiotherapy for retinoblastoma in the upfront (new diagnosis) setting?
In platinum-refractory or multiply-relapsed NSGCT with 1–2 progressive sites and no good surgical option, is there a role for local radiotherapy (e.g., SBRT) to those sites?
How will you treat an uterine embryonal rhabdomyosarcoma with regional node involvement resected to involved parametrial margins?
What is the optimal timing of salvage radiotherapy for recurrent metastatic neuroblastoma and what is the preferred dose and fractionation?
How do you decide on lung constraints for SBRT after whole lung radiation for persistent nodules?
Would you include the entire op bed (including flap) within the radiation field in a patient requiring a V-Y advancement flap for closure following a radical vulvectomy?
How long would you stop standard GBM radiotherapy if the patient had a fall with minor head trauma?
How would you optimally boost patients with high or very high risk prostate cancer receiving definitive radiotherapy in 2025?
How do you manage oxaliplatin-induced splenomegaly?
How long can a patient with newly diagnosed merkel cell carcinoma wait for wide local excision with sentinel node biopsy?